{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T12:37:29Z","timestamp":1742387849731},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T00:00:00Z","timestamp":1714780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T00:00:00Z","timestamp":1714780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>T-cell acute lymphoblastic leukemia (T-ALL) tends to involve central nervous system (CNS) infiltration at diagnosis. However, cases of residual CNS lesions detected at the end of induction and post early intensification have not been recorded in patients with T-ALL. Also, the ratio and prognosis of patients with residual intracranial lesions have not been defined.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 9-year-old boy with T-ALL had multiple intracranial tumors, which were still detected post early intensification. To investigate residual CNS lesions, we used <jats:sup>11<\/jats:sup>C-methionine (MET)-positron emission tomography. Negative MET uptake in CNS lesions and excellent MRD status in bone marrow allowed continuing therapies without hematopoietic cell transplantation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In cases with residual lesions on imaging studies, treatment strategies should be considered by the systemic response, direct assessment of spinal fluid, along with further development of noninvasive imaging methods in CNS. Further retrospective or prospective studies are required to determine the prognosis and frequency of cases with residual intracranial lesions after induction therapy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12887-024-04790-3","type":"journal-article","created":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T07:01:50Z","timestamp":1714806110000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Intracranial residual lesions following early intensification in a patient with T-cell acute lymphoblastic leukemia: a case report"],"prefix":"10.1186","volume":"24","author":[{"given":"Yuichi","family":"Nagamatsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Isoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoki","family":"Inaji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Oyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiki","family":"Niizato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Tomomasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Mitsuiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoi","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Kamiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohsuke","family":"Imai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Kanegane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Morio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatoshi","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,4]]},"reference":[{"issue":"3","key":"4790_CR1","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S1470-2045(08)70070-6","volume":"9","author":"CH Pui","year":"2008","unstructured":"Pui CH, Howard SC. Current management and challenges of malignant disease in the CNS in paediatric leukaemia. Lancet Oncol. 2008;9(3):257\u201368.","journal-title":"Lancet Oncol"},{"issue":"26","key":"4790_CR2","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1056\/NEJMoa0900386","volume":"360","author":"CH Pui","year":"2009","unstructured":"Pui CH, Campana D, Pei D, Bowman WP, Sandlund JT, Kaste SC, et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med. 2009;360(26):2730\u201341.","journal-title":"N Engl J Med"},{"issue":"2","key":"4790_CR3","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1200\/JCO.2003.04.096","volume":"21","author":"B B\u00fcrger","year":"2003","unstructured":"B\u00fcrger B, Zimmermann M, Mann G, K\u00fchl J, L\u00f6ning L, Riehm H, et al. Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia: significance of low leukocyte counts with blasts or traumatic lumbar puncture. J Clin Oncol. 2003;21(2):184\u20138.","journal-title":"J Clin Oncol"},{"issue":"5","key":"4790_CR4","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1056\/NEJM199307293290504","volume":"329","author":"HH Mahmoud","year":"1993","unstructured":"Mahmoud HH, Rivera GK, Hancock ML, Krance RA, Kun LE, Behm FG, et al. Low leukocyte counts with blast cells in cerebrospinal fluid of children with newly diagnosed acute lymphoblastic leukemia. N Engl J Med. 1993;329(5):314\u20139.","journal-title":"N Engl J Med"},{"issue":"1","key":"4790_CR5","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/pbc.26182","volume":"64","author":"S Ranta","year":"2017","unstructured":"Ranta S, Palom\u00e4ki M, Levinsen M, Taskinen M, Abrahamsson J, Mellgren K, et al. Role of neuroimaging in children with acute lymphoblastic leukemia and central nervous system involvement at diagnosis. Pediatr Blood Cancer. 2017;64(1):64\u201370.","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"4790_CR6","first-page":"86","volume":"15","author":"EM Ulu","year":"2009","unstructured":"Ulu EM, T\u00f6re HG, Bayrak A, G\u00fcng\u00f6r D, Co\u015fkun M. MRI of central nervous system abnormalities in childhood leukemia. Diagn Interv Radiol. 2009;15(2):86\u201392.","journal-title":"Diagn Interv Radiol"},{"issue":"12","key":"4790_CR7","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1182\/blood.2021012328","volume":"139","author":"S Buchmann","year":"2022","unstructured":"Buchmann S, Schrappe M, Baruchel A, Biondi A, Borowitz M, Campbell M, et al. Remission, treatment failure, and relapse in pediatric ALL: an international consensus of the Ponte-di-Legno Consortium. Blood. 2022;139(12):1785\u201393.","journal-title":"Blood"},{"issue":"15","key":"4790_CR8","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1056\/NEJMoa1110169","volume":"366","author":"M Schrappe","year":"2012","unstructured":"Schrappe M, Hunger SP, Pui CH, Saha V, Gaynon PS, Baruchel A, et al. Outcomes after induction failure in childhood acute lymphoblastic leukemia. N Engl J Med. 2012;366(15):1371\u201381.","journal-title":"N Engl J Med"},{"issue":"6","key":"4790_CR9","doi-asserted-by":"publisher","first-page":"e419","DOI":"10.1016\/S2352-3026(23)00072-8","volume":"10","author":"A Sato","year":"2023","unstructured":"Sato A, Hatta Y, Imai C, Oshima K, Okamoto Y, Deguchi T, et al. Nelarabine, intensive L-asparaginase, and protracted intrathecal therapy for newly diagnosed T-cell acute lymphoblastic leukaemia in children and young adults (ALL-T11): a nationwide, multicenter, phase 2 trial including randomisation in the very high-risk group. Lancet Haematol. 2023;10(6):e419\u201332.","journal-title":"Lancet Haematol"},{"key":"4790_CR10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.wneu.2021.01.004","volume":"148","author":"D Lee","year":"2021","unstructured":"Lee D, Omofoye OA, Nu\u00f1o MA, Riestenberg RA, Shahlaie K. Treatment outcomes of intracranial myeloid sarcomas: a meta-analysis. World Neurosurg. 2021;148:29\u201337.","journal-title":"World Neurosurg"},{"issue":"1","key":"4790_CR11","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/pbc.21562","volume":"51","author":"GD Cuvelier","year":"2008","unstructured":"Cuvelier GD, Vitali AM, Ford JC, Dix DB. Multiple intracranial tumors in Philadelphia chromosome positive acute lymphoblastic leukemia: successful treatment following aggressive supportive care, early cranial radiation, high dose chemotherapy and imatinib. Pediatr Blood Cancer. 2008;51(1):135\u20137.","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"4790_CR12","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s12185-013-1285-0","volume":"97","author":"N Hatakeyama","year":"2013","unstructured":"Hatakeyama N, Hori T, Yamamoto M, Inazawa N, Igarashi K, Tsutsumi H, et al. Multiple intracranial tumors in Philadelphia chromosome-positive acute lymphoblastic leukemia. Int J Hematol. 2013;97(4):441\u20132.","journal-title":"Int J Hematol"},{"issue":"26","key":"4790_CR13","doi-asserted-by":"publisher","first-page":"3062","DOI":"10.1200\/JCO.20.00531","volume":"38","author":"RJ Hayashi","year":"2020","unstructured":"Hayashi RJ, Winter SS, Dunsmore KP, Devidas M, Chen Z, Wood BL, et al. Successful outcomes of newly diagnosed T lymphoblastic lymphoma: results from Children\u2019s Oncology Group AALL0434. J Clin Oncol. 2020;38(26):3062\u201370.","journal-title":"J Clin Oncol"},{"issue":"4","key":"4790_CR14","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00259-012-2295-5","volume":"40","author":"AWJM Glaudemans","year":"2013","unstructured":"Glaudemans AWJM, Enting RH, Heesters MAAM, Dierckx RAJO, van Rheenen RWJ, Walenkamp AME, et al. Value of 11C-methionine PET in imaging brain tumours and metastases. Eur J Nucl Med Mol Imaging. 2013;40(4):615\u201335.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"4790_CR15","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3171\/jns.2005.103.3.0498","volume":"103","author":"T Nariai","year":"2005","unstructured":"Nariai T, Tanaka Y, Wakimoto H, Aoyagi M, Tamaki M, Ishiwata K, et al. Usefulness of L-[methyl-11C] methionine-positron emission tomography as a biological monitoring tool in the treatment of glioma. J Neurosurg. 2005;103(3):498\u2013507.","journal-title":"J Neurosurg"},{"issue":"2","key":"4790_CR16","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1159\/000490457","volume":"11","author":"T Nakano","year":"2018","unstructured":"Nakano T, Tamura K, Tanaka Y, Inaji M, Hayashi S, Kobayashi D, et al. Usefulness of (11)C-methionine positron emission tomography for monitoring of treatment response and recurrence in a glioblastoma patient on bevacizumab therapy: a case report. Case Rep Oncol. 2018;11(2):442\u20139.","journal-title":"Case Rep Oncol"},{"issue":"3","key":"4790_CR17","doi-asserted-by":"publisher","first-page":"419","DOI":"10.2967\/jnumed.116.178640","volume":"58","author":"SC Kaste","year":"2017","unstructured":"Kaste SC, Snyder SE, Metzger ML, Sandlund JT, Howard SC, Krasin M, et al. Comparison of (11)C-methionine and (18)F-FDG PET\/CT for staging and follow-up of pediatric lymphoma. J Nucl Medicine\u202f: official publication, Society of Nuclear Medicine. 2017;58(3):419\u201324.","journal-title":"J Nucl Medicine : official publication, Society of Nuclear Medicine"},{"issue":"21","key":"4790_CR18","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1182\/blood.V124.21.370.370","volume":"124","author":"N G\u00f6kbuget","year":"2014","unstructured":"G\u00f6kbuget N, Wolf A, Stelljes M, H\u00fcttmann A, Buss EC, Viardot A, et al. Favorable outcome in a large cohort of prospectively treated adult patients with T-lymphoblastic lymphoma (T-LBL) despite slowly evolving complete remission assessed by conventional radiography. Blood. 2014;124(21):370.","journal-title":"Blood"},{"issue":"8","key":"4790_CR19","doi-asserted-by":"publisher","first-page":"e259","DOI":"10.1097\/RLU.0000000000002154","volume":"43","author":"SY Ahn","year":"2018","unstructured":"Ahn SY, Kwon SY, Jung SH, Ahn JS, Yoo SW, Min JJ, et al. Prognostic significance of interim 11C-methionine PET\/CT in primary central nervous system lymphoma. Clin Nucl Med. 2018;43(8):e259\u201364.","journal-title":"Clin Nucl Med"},{"issue":"5","key":"4790_CR20","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/jjco\/hyaa010","volume":"50","author":"Y Miyakita","year":"2020","unstructured":"Miyakita Y, Ohno M, Takahashi M, Kurihara H, Katai H, Narita Y. Usefulness of carbon-11-labeled methionine positron-emission tomography for assessing the treatment response of primary central nervous system lymphoma. Jpn J Clin Oncol. 2020;50(5):512\u20138.","journal-title":"Jpn J Clin Oncol"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-024-04790-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-024-04790-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-024-04790-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T07:03:36Z","timestamp":1714806216000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-024-04790-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,4]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4790"],"URL":"https:\/\/doi.org\/10.1186\/s12887-024-04790-3","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,4]]},"assertion":[{"value":"17 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The JPLSG T11 protocol was approved by the ethics boards of Tokyo Medical and Dental University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the parents of the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conpeting interests"}}],"article-number":"304"}}